Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

A New Glycogen Storage Disease Caused by a Dominant PYGM Mutation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Comparing Seizure-Related Death and Suicide in Younger Adults with Epilepsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Genetic Susceptibility Loci in Genomewide Association Study of Cluster Headache

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Role of B Cells in Multiple Sclerosis and Related Disorders

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. MRI in Neuromuscular Diseases: An Emerging Diagnostic Tool and Biomarker for Prognosis and Efficacy

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Habitual Physical Activity in Patients with Myasthenia Gravis Assessed by Accelerometry and Questionnaire

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Muscle biopsy and MRI findings in ANO5-related myopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Nampt controls skeletal muscle development by maintaining Ca2+ homeostasis and mitochondrial integrity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Andoni Echaniz-Laguna
  • Xavière Lornage
  • Pascal Laforêt
  • Mette C Orngreen
  • Evelina Edelweiss
  • Guy Brochier
  • Mai T Bui
  • Roberto Silva-Rojas
  • Catherine Birck
  • Béatrice Lannes
  • Norma B Romero
  • John Vissing
  • Jocelyn Laporte
  • Johann Böhm
Vis graf over relationer

Objective: Glycogen storage diseases (GSDs) are severe human disorders resulting from abnormal glucose metabolism, and all previously described GSDs segregate as autosomal recessive or X-linked traits. In this study, we aimed to molecularly characterize the first family with a dominant GSD. Methods: We describe a dominant GSD family with 13 affected members presenting with adult-onset muscle weakness, and we provide clinical, metabolic, histological, and ultrastructural data. We performed exome sequencing to uncover the causative gene, and functional experiments in the cell model and on recombinant proteins to investigate the pathogenic effect of the identified mutation. Results: We identified a heterozygous missense mutation in PYGM segregating with the disease in the family. PYGM codes for myophosphorylase, the enzyme catalyzing the initial step of glycogen breakdown. Enzymatic tests revealed that the PYGM mutation impairs the AMP-independent myophosphorylase activity, whereas the AMP-dependent activity was preserved. Further functional investigations demonstrated an altered conformation and aggregation of mutant myophosphorylase, and the concurrent accumulation of the intermediate filament desmin in the myofibers of the patients. Interpretation: Overall, this study describes the first example of a dominant glycogen storage disease in humans, and elucidates the underlying pathomechanisms by deciphering the sequence of events from the PYGM mutation to the accumulation of glycogen in the muscle fibers. ANN NEUROL 2020;88:274–282.

OriginalsprogEngelsk
TidsskriftAnnals of Neurology
Vol/bind88
Udgave nummer2
Sider (fra-til)274-282
Antal sider9
ISSN0364-5134
DOI
StatusUdgivet - aug. 2020

Bibliografisk note

© 2020 American Neurological Association.

ID: 61073864